bioRxiv Science⌕ Search

Biology subjects

Sugatani, T.

Publications and source records attributed to Sugatani, T..

2 recordsLinked to original sources

N-cadherin in osteolineage cells restrains breast cancer cell growth via inhibition of a PI3K-dependent, Tgf-β1-driven feed-forward loop

Tumor growth and metastases are affected by interactions between tumor and microenvironment cells. We have reported the presence of Sp7-positive cells with an osteogenic signature in primary mouse breast cancer, where they stimulate tumor growth; and genetic ablation of Cdh2 (encoding N-cadherin) in these cells enhances their pro-tumorigenic action. To study the molecular mechanisms of this biologic system, we used MC3T3 cells, phenotypically similar to tumor associated osteolineage cells. Ablation of Cdh2 in MC3T3 cells enhances PI3K-Akt-{beta}-catenin signaling in response to transforming growth factor-{beta}1 (Tgf-{beta}1), resulting in increased production of Tgf-{beta}1. Interference with PI3K activity is mediated by N-cadherin binding to PI3K components, p85 and p100, resulting in reduced activation of PI3K-Akt-{beta}-catenin signaling. Downstream, Cdh2 ablation enhances Tgf-{beta}1-induced binding of Sp1 and Lef-1 to the Tgfb1 promoter, leading to increased promoter activity and enhanced Tgf-{beta}1 production. This is associated with miR-21 up-regulation and decreased expression of Pten, a PI3K inhibitor. MC3T3 cells promote growth of breast cancer cells (BCC) when co-cultured in vitro or co-injected in mouse mammary fat pad, and Cdh2-deficiency enhances this pro-tumorigenic effect. Notably, genetic ablation of the Tgf-{beta}1 receptor subunit, Tgfbr1, in BCC abrogates the pro-tumorigenic action of MC3T3 cells and its enhancement by Cdh2 ablation. Finally, Sp7-driven Tgfbr1 ablation in mice also reduces the growth of BCC in the mammary fat pad. Thus, autocrine Tgf-{beta}1 production via PI3K-Akt-{beta}-catenin signaling is a key mechanism by which osteolineage cells promote BCC growth, an action restrained by Ncad via interference with PI3K components. HighlightsO_LIIn tumor-associated osteolineage cells, N-cadherin reduces the growth of breast tumors; it also inhibits Tgf-{beta}1-activated PI3K/AKT/{beta}-catenin signaling C_LIO_LITgf-{beta}1 produced by tumor microenvironment cells stimulates breast cancer cell growth and further autocrine production of Tgf-{beta}1 C_LIO_LIThe anti-tumorigenic action of N-cadherin is mediated by a braking effect on a Tgf-{beta}1-driven, pro-tumorigenic, feed-forward cycle between microenvironment and tumor cells. C_LI

cancer biology↗

Connexin43 in mesenchymal lineage cells regulates body adiposity and energy metabolism in mice

Connexin43 (Cx43) is the most abundant gap junction protein present in the mesenchymal lineage. In mature adipocytes, Cx43 mediates white adipose tissue (WAT) "beiging" in response to cold exposure and maintains the mitochondrial integrity of brown adipose tissue (BAT). We found that genetic deletion of Gja1 (Cx43 gene) in cells that give rise to chondro-osteogenic and adipogenic precursors driven by the Dermo1/Twist2 promoter leads to lower body adiposity and partial protection against the weight gain and metabolic syndrome induced by a high fat diet (HFD) in both sexes. These protective effects from obesogenic diet are related to increased locomotion, fuel utilization, energy expenditure, non-shivering thermogenesis, and better glucose tolerance in conditionally Gja1 ablated mice. Accordingly, Gja1 mutant mice exhibit reduced adipocyte hypertrophy, partially preserved insulin sensitivity, increased BAT lipolysis and decreased whitening under HFD. This metabolic phenotype is not reproduced with more restricted Gja1 ablation in differentiated adipocytes, suggesting that Cx43 has a hitherto unknown function in adipocyte progenitors or other targeted cells, resulting in restrained energy expenditures and fat accumulation. These results disclose an hitherto unknown action of Cx43 in adiposity, and offer a promising new pharmacologic target for improving metabolic balance in diabetes and obesity. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=157 HEIGHT=200 SRC="FIGDIR/small/574415v1_ufig1.gif" ALT="Figure 1"> View larger version (72K): org.highwire.dtl.DTLVardef@1ade7d3org.highwire.dtl.DTLVardef@4edbd7org.highwire.dtl.DTLVardef@1431c1borg.highwire.dtl.DTLVardef@ea6bbb_HPS_FORMAT_FIGEXP M_FIG C_FIG

physiology↗